Pharma Friday – November 21, 2026

Published on November 20, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Amylyx Pharmaceuticals Presents Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia On November 14, Amylyx Pharmaceuticals, Inc. presented the results from the 16-week double-blind treatment period of the Phase 3 LUCIDITY clinical trial of avexitide, an investigational, […]

The post Pharma Friday – November 21, 2026 appeared first on Endocrine News.